Editing Azithromycin (section)

== History ==
A team of researchers at the pharmaceutical company Pliva in Zagreb, Croatia discovered azithromycin in 1980.<ref>{{cite journal | vauthors = Banić Tomišić Z | title = The Story of Azithromycin | journal = Kemija U Industriji: Časopis Kemičara I Kemijskih Inženjera Hrvatske. | date = December 2011 | volume = 60 | issue = 12 | pages = 603–17 | url = https://www.researchgate.net/publication/286136408 | access-date = 25 June 2020 | archive-date = 8 March 2024 | archive-url = https://web.archive.org/web/20240308023348/https://www.researchgate.net/publication/286136408_The_Story_of_Azithromycin | url-status = live }}</ref> The company Pliva patented it in 1981.<ref name=Fis2006/> In 1986, Pliva and [[Pfizer]] signed a licensing agreement, which gave Pfizer exclusive rights for the sale of azithromycin in Western Europe and the United States. Pliva put its azithromycin on the market in Central and Eastern Europe. Pfizer launched azithromycin under Pliva's license in other markets under the brand name Zithromax in 1991.<ref>{{cite journal| vauthors = Banić Tomišić Z |title=The Story of Azithromycin|journal=Kemija U Industriji|year=2011|volume=60|issue=12|pages=603–617|issn=0022-9830|url=http://pierre.fkit.hr/hdki/kui/en/vol60/abstracts/617.html|url-status=dead|archive-url=https://web.archive.org/web/20170908161922/http://pierre.fkit.hr/hdki/kui/en/vol60/abstracts/617.html|archive-date=8 September 2017|access-date=15 April 2013}}</ref> Patent protection ended in 2005.<ref>{{cite web|url=https://www.wipo.int/ipadvantage/en/details.jsp?id=906|title=Azithromycin: A world best-selling Antibiotic|website=www.wipo.int|publisher=World Intellectual Property Organization|access-date=18 June 2019|archive-date=6 December 2020|archive-url=https://web.archive.org/web/20201206082124/https://www.wipo.int/ipadvantage/en/details.jsp?id=906|url-status=live}}</ref>